Skip to main content

JHOP - February 2026 Vol 16, No 1

Case Reports
Original Research
Case Reports
Online First
Case Reports, Adverse Events, Antibody–Drug Conjugates , Infusion Issues, Monoclonal Antibodies
Attenuation of Rash From Fam-Trastuzumab Deruxtecan-nxki Via a Desensitization Protocol: A Case Report
Stephanie Budhan, BS; Blanka Kaplan, MD; Grace Kwan-Mangal, PharmD, RPh; Anthony Szema, MD
Read More
Online First
Case Reports, Adverse Events, Drug–Drug Interaction, Breast Cancer
Simvastatin-Induced Rhabdomyolysis Potentially Triggered by Palbociclib Inhibition of CYP3A4: A Case Report
Madeleine Hosick, PharmD; Karam Abi Karam, DO; Kaitlyn Korah, PharmD; Kyla Bidne, PharmD, BCOP; Diana Tamer, PharmD, BCOP
Read More
Original Research
Online First
Original Research, Chemotherapy, Adverse Events
Evaluation of Bleeding Events in Patients Who Received Ibrutinib With or Without Antithrombotic Therapy
Frank A. Lattuca, PharmD, BCOP; Jeremiah E. Moore, PharmD, BCOP; Carissa Treptow, PharmD, BCOP; Kendra Delibert, PharmD, BCOP; Andrea Baran, MS; Clive S. Zent, MD
Read More
Online First
Original Research, Acute Lymphoblastic Leukemia, Anticoagulants, Thromboembolism
Evaluation of Clotting and Bleeding Risk Associated With the Use of Asparaginase Drugs in Patients With Acute Lymphoblastic Leukemia
Alyssa Cendagorta, PharmD, BCOP; Frank Lattuca, PharmD, BCOP; Jeremiah E. Moore, PharmD, BCOP; Kristen O’Dwyer, MD; Andrea Baran, MS; Nicole M. Acquisto, PharmD, FASHP, FCCM, FCCP, BCCCP; Carissa Treptow, PharmD, BCOP
Read More
Online First
Original Research, Adverse Events, Multiple Myeloma, Immunotherapy, Thromboembolism
Assessment of Appropriate Anticoagulation in Patients With Multiple Myeloma—A Health-System Specialty Pharmacy Retrospective Evaluation
Addie Planas, PharmD, CSP, CPh; Brittany Alvarez, PharmD, MBA; Beatriz Jimenez Cadilla, PharmD, BCACP; Karina Delgado, PharmD, MBA, BCPS; Jacqualine Igwe, PharmD, BCPS, et al.
Read More